Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening
Endocrine Abstracts
doi 10.1530/endoabs.41.ep889
Full Text
Open PDFAbstract
Available in full text
Date
May 13, 2016
Authors
Publisher
Bioscientifica